---
title: 'Resmetirom and Metabolic Dysfunction-Associated Steatohepatitis: Perspectives
  on Multidisciplinary Management from Global Healthcare Professionals'
date: '2024-08-07'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39110384/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240807181614&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'PURPOSE OF REVIEW: The approval of resmetirom brings great hope to patients
  with metabolic dysfunction-associated steatohepatitis (MASH). The purpose of this
  review is to explore its impact on the global health environment. The implementation
  of multidisciplinary management MASH is ...'
disable_comments: true
---
PURPOSE OF REVIEW: The approval of resmetirom brings great hope to patients with metabolic dysfunction-associated steatohepatitis (MASH). The purpose of this review is to explore its impact on the global health environment. The implementation of multidisciplinary management MASH is ...